DMAQ
Income statement / Annual
Last year (2022), Deep Medicine Acquisition Corp.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2022, Deep Medicine Acquisition Corp.'s net income was -$400,232.00.
See Deep Medicine Acquisition Corp.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2022
|
FY-2021
|
| Period Ended |
03/31/2023 |
03/31/2022 |
| Operating Revenue |
$0.00 |
$0.00 |
| Cost of Revenue |
$60,000.00
|
$60,000.00
|
| Gross Profit |
-$60,000.00
|
-$60,000.00
|
| Gross Profit Ratio |
0
|
0
|
| Research and Development Expenses |
$0.00
|
$0.00
|
| General & Administrative Expenses |
$1.91 M
|
$409,912.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$1.91 M
|
$409,912.00
|
| Other Expenses |
$200,000.00
|
$60,000.00
|
| Operating Expenses |
$2.11 M
|
$409,912.00
|
| Cost And Expenses |
$2.17 M
|
$409,912.00
|
| Interest Income |
$0.00
|
$0.00
|
| Interest Expense |
$0.00
|
$8,266.00
|
| Depreciation & Amortization |
-$3.65 M
|
$55,867.00
|
| EBITDA |
-$3.99 M |
-$405,779.00 |
| EBITDA Ratio |
0
|
0
|
| Operating Income Ratio |
0
|
0
|
| Total Other Income/Expenses Net |
$1.88 M
|
$47,601.00
|
| Income Before Tax |
-$342,663.00
|
-$414,045.00
|
| Income Before Tax Ratio |
0
|
0
|
| Income Tax Expense |
$57,569.00
|
-$55,867.00
|
| Net Income |
-$400,232.00
|
-$358,178.00
|
| Net Income Ratio |
0
|
0
|
| EPS |
-0.17 |
-0.041 |
| EPS Diluted |
-0.17 |
-0.041 |
| Weighted Average Shares Out |
$2.31 M
|
$8.74 M
|
| Weighted Average Shares Out Diluted |
$2.31 M
|
$8.74 M
|
| Link |
|
|
